Vertex Stock Performance

VRTX
 Stock
  

USD 303.00  2.53  0.83%   

On a scale of 0 to 100, Vertex Pharmaceutic holds a performance score of 11. The entity has a beta of 0.9274, which indicates possible diversification benefits within a given portfolio. Let's try to break down what Vertex's beta means in this case. Vertex Pharmaceutic returns are very sensitive to returns on the market. As the market goes up or down, Vertex Pharmaceutic is expected to follow. Although it is vital to follow Vertex Pharmaceutic current price movements, it is good to be conservative about what you can do with the information regarding equity historical returns. The philosophy towards measuring future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By inspecting Vertex Pharmaceutic technical indicators, you can presently evaluate if the expected return of 0.3% will be sustainable into the future. Please operates Vertex Pharmaceutic value at risk, kurtosis, market facilitation index, as well as the relationship between the semi variance and rate of daily change to make a quick decision on whether Vertex Pharmaceutic existing price patterns will revert.
  
Vertex Performance
11 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Vertex Pharmaceutic are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Vertex Pharmaceutic showed solid returns over the last few months and may actually be approaching a breakup point. ...more

Structure and Payout Changes

Last Split Factor
2:1
Last Split Date
2000-08-24

Vertex Price Channel

Quick Ratio4.14
Fifty Two Week Low176.36
Target High Price389.00
Fifty Two Week High305.95
Target Low Price250.00

Vertex Pharmaceutic Relative Risk vs. Return Landscape

If you would invest  25,545  in Vertex Pharmaceutic on May 19, 2022 and sell it today you would earn a total of  4,755  from holding Vertex Pharmaceutic or generate 18.61% return on investment over 90 days. Vertex Pharmaceutic is currently generating 0.2999% in daily expected returns and assumes 1.9989% risk (volatility on return distribution) over the 90 days horizon. In different words, 17% of stocks are less volatile than Vertex, and 95% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Daily Expected Return (%)  
       Risk (%)  
Given the investment horizon of 90 days Vertex Pharmaceutic is expected to generate 1.7 times more return on investment than the market. However, the company is 1.7 times more volatile than its market benchmark. It trades about 0.15 of its potential returns per unit of risk. The DOW is currently generating roughly 0.13 per unit of risk.

Vertex Pharmaceutic Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Vertex Pharmaceutic's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Vertex Pharmaceutic, and traders can use it to determine the average amount a Vertex Pharmaceutic's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.15

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small ReturnsVRTX
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative Returns
Estimated Market Risk
 2.0
  actual daily
 
 17 %
of total potential
 
1717
Expected Return
 0.3
  actual daily
 
 5 %
of total potential
 
55
Risk-Adjusted Return
 0.15
  actual daily
 
 11 %
of total potential
 
1111
Based on monthly moving average Vertex Pharmaceutic is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vertex Pharmaceutic by adding it to a well-diversified portfolio.

About Vertex Pharmaceutic Performance

To evaluate Vertex Pharmaceutic Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Vertex Pharmaceutic generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Vertex Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Vertex Pharmaceutic market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Vertex's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Effect of Exchange Rate Changes on Cash-5.4 M-5.5 M
Return on Investment 28.05  30.26 
Return on Average Assets 18.60  20.07 
Return on Average Equity 24.93  26.90 
Return on Invested Capital(0.0081) (0.008739) 
Return on Sales(0.0072) (0.007768) 
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts. Vertex Pharmaceutic operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 00 people.

Things to note about Vertex Pharmaceutic

Checking the ongoing alerts about Vertex Pharmaceutic for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Vertex Pharmaceutic help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Vertex Pharmaceutic Alerts

Equity Alerts and Improvement Suggestions

Vertex Pharmaceutic is unlikely to experience financial distress in the next 2 years
Over 95.0% of the company outstanding shares are owned by institutional investors
Latest headline from www.nasdaq.com: Sale by Liu Joy of tradable shares of Vertex Pharmaceutic
Also, please take a look at World Market Map. Note that the Vertex Pharmaceutic information on this page should be used as a complementary analysis to other Vertex Pharmaceutic's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Complementary Tools for Vertex Stock analysis

When running Vertex Pharmaceutic price analysis, check to measure Vertex Pharmaceutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceutic is operating at the current time. Most of Vertex Pharmaceutic's value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceutic's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Vertex Pharmaceutic's price. Additionally, you may evaluate how the addition of Vertex Pharmaceutic to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Is Vertex Pharmaceutic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vertex Pharmaceutic. If investors know Vertex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vertex Pharmaceutic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
11.1
Market Capitalization
78.4 B
Quarterly Revenue Growth YOY
0.23
Return On Assets
0.14
Return On Equity
0.3
The market value of Vertex Pharmaceutic is measured differently than its book value, which is the value of Vertex that is recorded on the company's balance sheet. Investors also form their own opinion of Vertex Pharmaceutic's value that differs from its market value or its book value, called intrinsic value, which is Vertex Pharmaceutic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vertex Pharmaceutic's market value can be influenced by many factors that don't directly affect Vertex Pharmaceutic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vertex Pharmaceutic's value and its price as these two are different measures arrived at by different means. Investors typically determine Vertex Pharmaceutic value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vertex Pharmaceutic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.